{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T01:45:22Z","timestamp":1784684722670,"version":"3.55.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hormones"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1007\/bf03401344","type":"journal-article","created":{"date-parts":[[2018,8,8]],"date-time":"2018-08-08T05:30:48Z","timestamp":1533706248000},"page":"290-295","source":"Crossref","is-referenced-by-count":19,"title":["Brain and optic chiasmal herniation following cabergoline treatment for a giant prolactinoma: wait or intervene?"],"prefix":"10.1007","volume":"13","author":[{"given":"Labrini","family":"Papanastasiou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stelios","family":"Fountoulakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodora","family":"Pappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Liberopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimosthenis","family":"Malliopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athina","family":"Markou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Piaditis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,4,1]]},"reference":[{"key":"BF03401344_CR1","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1056\/NEJMcp025334","volume":"349","author":"JA Schlechte","year":"2003","unstructured":"Schlechte JA, 2003 Clinical practice. Prolactinoma. N Engl J Med 349: 2035\u20132041.","journal-title":"N Engl J Med"},{"key":"BF03401344_CR2","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1210\/er.2005-9998","volume":"27","author":"MP Gillam","year":"2006","unstructured":"Gillam MP, Molitch ME, Lombardi G, Colao A, 2006 Advances in the treatment of prolactinomas. Endocr Rev 27: 485\u2013534.","journal-title":"Endocr Rev"},{"key":"BF03401344_CR3","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1210\/jc.2010-1692","volume":"96","author":"S Melmed","year":"2011","unstructured":"Melmed S, Casanueva FF, Hoffman AR, et al, 2011 Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96: 273\u2013288.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03401344_CR4","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/nrendo.2011.37","volume":"7","author":"A Colao","year":"2011","unstructured":"Colao A, Savastano S, 2011 Medical treatment of prolactinomas. Nat Rev Endocrinol 7: 267\u2013278.","journal-title":"Nat Rev Endocrinol"},{"key":"BF03401344_CR5","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1056\/NEJM198101153040306","volume":"304","author":"GN Burrow","year":"1981","unstructured":"Burrow GN, Wortzman G, Rewcastle NB, Holgate RC, Kovacs K, 1981 Microadenomas of the pituitary and abnormal sellar tomograms in an unselected autopsy series. N Engl J Med 304: 156\u2013158.","journal-title":"N Engl J Med"},{"key":"BF03401344_CR6","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1046\/j.1365-2265.2003.01770.x","volume":"58","author":"SM Corsello","year":"2003","unstructured":"Corsello SM, Ubertini G, Altomare M, et al, 2003 Giant prolactinomas in men: efficacy of cabergoline treatment. Clin Endocrinol (Oxf) 58: 662\u2013670.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"BF03401344_CR7","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3171\/jns.2002.97.2.0299","volume":"97","author":"RK Shrivastava","year":"2002","unstructured":"Shrivastava RK, Arginteanu MS, King WA, Post KD, 2002 Giant prolactinomas: clinical management and long-term follow up. J Neurosurg 97: 299\u2013306.","journal-title":"J Neurosurg"},{"key":"BF03401344_CR8","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1530\/EJE-12-0236","volume":"167","author":"L Vroonen","year":"2012","unstructured":"Vroonen L, Jaffrain-Rea ML, Petrossians P, et al, 2012 Prolactinomas resistant to standard doses of cabergoline: a multicenter study of 92 patients. Eur J Endocrinol 167: 651\u2013662.","journal-title":"Eur J Endocrinol"},{"key":"BF03401344_CR9","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s11102-005-5349-x","volume":"7","author":"M Knoepfelmacher","year":"2004","unstructured":"Knoepfelmacher M, Gomes MC, Melo ME, Mendonca BB, 2004 Pituitary apoplexy during therapy with cabergoline in an adolescent male with prolactin-secreting macroadenoma. Pituitary 7: 83\u201387.","journal-title":"Pituitary"},{"key":"BF03401344_CR10","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1046\/j.1365-2265.2000.00901.x","volume":"52","author":"KS Leong","year":"2000","unstructured":"Leong KS, Foy PM, Swift AC, Atkin SL, Hadden DR, MacFarlane IA, 2000 CSF rhinorrhoea following treatment with dopamine agonists for massive invasive prolactinomas. Clin Endocrinol (Oxf) 52: 43\u201349.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"BF03401344_CR11","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1046\/j.1365-2265.2000.01039.x","volume":"53","author":"SE Jones","year":"2000","unstructured":"Jones SE, James RA, Hall K, Kendall-Taylor P, 2000 Optic chiasmal herniation\u2014an under recognized complication of dopamine agonist therapy for macroprolactinoma. Clin Endocrinol (Oxf) 53: 529\u2013534.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"BF03401344_CR12","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1017\/S0317167100005060","volume":"33","author":"MH Bangash","year":"2006","unstructured":"Bangash MH, Clarke DB, Holness RO, 2006 Brain & chiasmal herniations into sella after medical treatment of prolactinoma. Can J Neurol Sci 33: 240\u2013242.","journal-title":"Can J Neurol Sci"},{"key":"BF03401344_CR13","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1007\/s11102-009-0179-x","volume":"14","author":"DK Dhanwal","year":"2011","unstructured":"Dhanwal DK, Sharma AK, 2011 Brain and optic chiasmal herniations into sella after cabergoline therapy of giant prolactinoma. Pituitary 14: 384\u2013387.","journal-title":"Pituitary"},{"key":"BF03401344_CR14","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s00701-012-1613-9","volume":"155","author":"N Gkekas","year":"2013","unstructured":"Gkekas N, Primikiris P, Georgakoulias N, 2013 Untethering of herniated left optic nerve after dopamine agonist treatment for giant prolactinoma. Acta Neurochir (Wien) 155: 495\u2013496.","journal-title":"Acta Neurochir (Wien)"},{"key":"BF03401344_CR15","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1530\/EJE-06-0646","volume":"156","author":"I Shimon","year":"2007","unstructured":"Shimon I, Benbassat C, Hadani M, 2007 Effectiveness of long-term cabergoline treatment for giant prolactinoma: study of 12 men. Eur J Endocrinol 156: 225\u2013231.","journal-title":"Eur J Endocrinol"},{"key":"BF03401344_CR16","doi-asserted-by":"publisher","first-page":"42","DOI":"10.4158\/EP09221.OR","volume":"16","author":"SV Acharya","year":"2010","unstructured":"Acharya SV, Gopal RA, Menon PS, Bandgar TR, Shah NS, 2010 Giant prolactinoma and effectiveness of medical management. Endocr Pract 16: 42\u201346.","journal-title":"Endocr Pract"},{"key":"BF03401344_CR17","doi-asserted-by":"publisher","first-page":"3574","DOI":"10.1210\/jcem.82.11.4368","volume":"82","author":"A Colao","year":"1997","unstructured":"Colao A, Di Sarno A, Landi ML, et al, 1997 Long-term and low-dose treatment with cabergoline induces macroprolactinoma shrinkage. J Clin Endocrinol Metab 82: 3574\u20133579.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03401344_CR18","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s11102-005-5085-2","volume":"8","author":"ME Molitch","year":"2005","unstructured":"Molitch ME, 2005 Pharmacologic resistance in prolactinoma patients. Pituitary 8: 43\u201352.","journal-title":"Pituitary"},{"key":"BF03401344_CR19","first-page":"227","volume":"74","author":"JR Davis","year":"1990","unstructured":"Davis JR, Sheppard MC, Heath DA, 1990 Giant invasive prolactinoma: a case report and review of nine further cases. Q J Med 74: 227\u2013238.","journal-title":"Q J Med"},{"issue":"Suppl 1","key":"BF03401344_CR20","first-page":"27","volume":"129","author":"M Besser","year":"1993","unstructured":"Besser M, 1993 Criteria for medical as opposed to surgical treatment of prolactinomas. Acta Endocrinol (Copenh) 129: Suppl 1: 27\u201330.","journal-title":"Acta Endocrinol (Copenh)"},{"key":"BF03401344_CR21","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/BF01815445","volume":"8","author":"HW Pia","year":"1985","unstructured":"Pia HW, Grote E, Hildebrandt G, 1985 Giant pituitary adenomas. Neurosurg Rev 8: 207\u2013220.","journal-title":"Neurosurg Rev"},{"key":"BF03401344_CR22","doi-asserted-by":"publisher","first-page":"597","DOI":"10.2214\/ajr.152.3.597","volume":"152","author":"B Kaufman","year":"1989","unstructured":"Kaufman B, Tomsak RL, Kaufman BA, et al, 1989 Herniation of the suprasellar visual system and third ventricle into empty sellae: morphologic and clinical considerations. AJR Am J Roentgenol 152: 597\u2013608.","journal-title":"AJR Am J Roentgenol"},{"key":"BF03401344_CR23","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1097\/00041327-199612000-00005","volume":"16","author":"P Taxel","year":"1996","unstructured":"Taxel P, Waitzman DM, Harrington JF Jr, et al, 1996 Chiasmal herniation as a complication of bromocriptine therapy. J Neuroophthalmol 16: 252\u2013257.","journal-title":"J Neuroophthalmol"},{"key":"BF03401344_CR24","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1097\/00041327-200206000-00008","volume":"22","author":"H Chuman","year":"2002","unstructured":"Chuman H, Cornblath WT, Trobe JD, Gebarski SS, 2002 Delayed visual loss following pergolide treatment of a prolactinoma. J Neuroophthalmol 22: 102\u2013106.","journal-title":"J Neuroophthalmol"},{"key":"BF03401344_CR25","first-page":"1279","volume":"13","author":"P Lundin","year":"1992","unstructured":"Lundin P, Bergstr\u00f6m K, Nyman R, Lundberg PO, Muhr C, 1992 Macroprolactinomas: serial MR imaging in longterm bromocriptine therapy. AJNR Am J Neuroradiol 13: 1279\u20131291.","journal-title":"AJNR Am J Neuroradiol"},{"key":"BF03401344_CR26","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s11102-007-0072-4","volume":"11","author":"ZB Wu","year":"2008","unstructured":"Wu ZB, Su ZP, Wu JS, Zheng WM, Zhuge QC, Zhong M, 2008 Five years follow-up of invasive prolactinomas with special reference to the control of cavernous sinus invasion. Pituitary 11: 63\u201370.","journal-title":"Pituitary"},{"key":"BF03401344_CR27","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1111\/j.1365-2265.2008.03364.x","volume":"70","author":"G Raverot","year":"2009","unstructured":"Raverot G, Jacob M, Jouanneau E, et al, 2009 Secondary deterioration of visual field during cabergoline treatment for macroprolactinoma. Clin Endocrinol (Oxf) 70: 588\u2013592.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"BF03401344_CR28","doi-asserted-by":"publisher","first-page":"3180","DOI":"10.1210\/jcem.87.7.8645","volume":"87","author":"M Losa","year":"2002","unstructured":"Losa M, Mortini P, Barzaghi R, Gioia L, Giovanelli M, 2002 Surgical treatment of prolactin-secreting pituitary adenomas: early results and long-term outcome. J Clin Endocrinol Metab 87: 3180\u20133186.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03401344_CR29","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S1042-3680(02)00033-5","volume":"14","author":"JK Liu","year":"2003","unstructured":"Liu JK, Weiss MH, Couldwell WT, 2003 Surgical approaches to pituitary tumors. Neurosurg Clin N Am 14: 93\u2013107.","journal-title":"Neurosurg Clin N Am"},{"key":"BF03401344_CR30","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1586\/14737140.6.9s.S79","volume":"9","author":"W Musleh","year":"2006","unstructured":"Musleh W, Sonabend AM, Lesniak MS, 2006 Role of craniotomy in the management of pituitary adenomas and sellar\/parasellar tumors. Expert Rev Anticancer Ther Suppl 9: 79\u201383.","journal-title":"Expert Rev Anticancer Ther Suppl"},{"key":"BF03401344_CR31","doi-asserted-by":"publisher","first-page":"527","DOI":"10.3171\/jns.1977.46.4.0527","volume":"46","author":"RE Decker","year":"1977","unstructured":"Decker RE, Carras R, 1977 Transsphenoidal chiasmapexy for correction of posthypophysectomy traction syndrome of optic chiasm. Case report. J Neurosurg 46: 527\u2013529.","journal-title":"J Neurosurg"},{"key":"BF03401344_CR32","doi-asserted-by":"publisher","first-page":"428","DOI":"10.2176\/nmc.45.428","volume":"45","author":"S Kubo","year":"2005","unstructured":"Kubo S, Hasegawa H, Inui T, Tominaga S, Yoshimine T, 2005 Endonasal endoscopic transsphenoidal chiasmapexy with silicone plates for empty sella syndrome: technical note. Neurol Med Chir (Tokyo) 45: 428\u2013432.","journal-title":"Neurol Med Chir (Tokyo)"}],"container-title":["Hormones"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03401344\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03401344.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03401344.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,8,15]],"date-time":"2018-08-15T22:13:30Z","timestamp":1534371210000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03401344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["BF03401344"],"URL":"https:\/\/doi.org\/10.1007\/bf03401344","relation":{},"ISSN":["1109-3099","2520-8721"],"issn-type":[{"value":"1109-3099","type":"print"},{"value":"2520-8721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4]]}}}